GSK1119711A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK1119711A, covering 2019-10-28 to 2019-10-28. Get the full timeline:
Most recent: Clinical Trial Update: Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A) [Phase 2]